Suppr超能文献

人脑微透析液的蛋白质组

The proteome of human brain microdialysate.

作者信息

Maurer Martin H, Berger Christian, Wolf Margit, Fütterer Carsten D, Feldmann Robert E, Schwab Stefan, Kuschinsky Wolfgang

机构信息

Dept, of Physiology and Pathophysiology, University of Heidelberg, Im Neuenheimer Feld 326, 69120 Heidelberg, Germany.

出版信息

Proteome Sci. 2003 Dec 14;1(1):7. doi: 10.1186/1477-5956-1-7.

Abstract

BACKGROUND

Cerebral microdialysis has been established as a monitoring tool in neurocritically ill patients suffering from severe stroke. The technique allows to sample small molecules in the brain tissue for subsequent biochemical analysis. In this study, we investigated the proteomic profile of human cerebral microdialysate and if the identified proteins might be useful predictors for disease characteristics in stroke for tissue at risk in the contralateral hemisphere. We analysed cerebral protein expression in microdialysate from three stroke patients sampled from the hemisphere contralateral to the lesion. Using a proteomic approach based on two-dimensional gel electrophoresis and subsequent mass spectrometry, we created a protein map for the global protein expression pattern of human microdialyste. RESULTS: We found an average of 158 +/- 24 (N = 18) protein spots in the human cerebral microdialysate and could identify 95 spots, representing 27 individual proteins. Most of these have been detected in human cerebrospinal fluid before, but 10 additional proteins mainly of cerebral intracellular origin were identified exclusively in the microdialysate. CONCLUSIONS: The 10 proteins found exclusively in human cerebral microdialysate, but not in cerebrospinal fluid, indicate the possibility to monitor the progression of the disease towards deterioration. The correlation of protein composition in the human cerebral microdialysate with the patients' clinical condition and results of cerebral imaging may be a useful approach to future applications for neurological stroke diagnosis, prognosis, and treatment.

摘要

背景

脑微透析已成为重症中风神经危重症患者的一种监测工具。该技术能够对脑组织中的小分子进行采样,以便后续进行生化分析。在本研究中,我们调查了人脑微透析液的蛋白质组学特征,以及所鉴定出的蛋白质是否可能成为对侧半球有风险组织中风疾病特征的有用预测指标。我们分析了来自三名中风患者病变对侧半球微透析液中的脑蛋白表达。使用基于二维凝胶电泳和后续质谱分析的蛋白质组学方法,我们创建了人脑微透析液全局蛋白质表达模式的蛋白质图谱。结果:我们在人脑微透析液中平均发现了158±24个(N = 18)蛋白质斑点,并能够鉴定出95个斑点,代表27种不同的蛋白质。其中大多数之前已在人脑脊液中检测到,但另外10种主要源自脑细胞内的蛋白质仅在微透析液中被鉴定出来。结论:仅在人脑微透析液中而非脑脊液中发现的这10种蛋白质,表明有可能监测疾病向恶化发展的进程。人脑微透析液中蛋白质组成与患者临床状况及脑成像结果之间的相关性,可能是未来用于神经中风诊断、预后和治疗的一种有用方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96ba/317363/7eac7b890769/1477-5956-1-7-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验